NCT01697800View on ClinicalTrials.gov

A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

July 14, 2014

Study Completion Date

July 14, 2014

Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
DRUG

Tadalafil

DRUG

Placebo

Trial Locations (1)

21231

Johns Hopkins Hospital, Baltimore

All Listed Sponsors
collaborator

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT01697800 - A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract | Biotech Hunter | Biotech Hunter